Akebia Therapeutics, Inc. (AKBA)
0.9833
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
0.9812
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Cash from Investing (Quarterly) : -4.079M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.079M |
| March 31, 2026 | -0.062M |
| December 31, 2025 | -7.877M |
| September 30, 2025 | -0.077M |
| June 30, 2025 | -0.126M |
| March 31, 2025 | 0.154M |
| December 31, 2024 | -0.002M |
| September 30, 2024 | -0.002M |
| June 30, 2024 | -0.029M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.114M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 20.00M |
| March 31, 2021 | 19.94M |
| December 31, 2020 | 59.68M |
| September 30, 2020 | -49.94M |
| June 30, 2020 | -50.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.245M |
| December 31, 2019 | 22.28M |
| September 30, 2019 | 24.39M |
| June 30, 2019 | 54.03M |
| March 31, 2019 | 110.47M |
| December 31, 2018 | 16.72M |
| September 30, 2018 | 11.01M |
| June 30, 2018 | -3.568M |
| March 31, 2018 | 12.43M |
| December 31, 2017 | -8.308M |
| September 30, 2017 | -44.96M |
| June 30, 2017 | -31.69M |
| March 31, 2017 | -92.30M |
| December 31, 2016 | 22.31M |
| September 30, 2016 | 45.57M |
| June 30, 2016 | 29.79M |
| March 31, 2016 | -84.96M |
| December 31, 2015 | 1.638M |
| September 30, 2015 | -14.46M |
| June 30, 2015 | -4.276M |
| March 31, 2015 | 3.405M |
| December 31, 2014 | -7.637M |
| September 30, 2014 | -40.00M |
| June 30, 2014 | -23.07M |
| March 31, 2014 | 5.358M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Emergent BioSolutions, Inc. | -52.30M |
| Exelixis, Inc. | 91.43M |
| ADMA Biologics, Inc. | -2.256M |
| Arcutis Biotherapeutics, Inc. | -15.22M |
| Relay Therapeutics, Inc. | -353.03M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.525M |
| Cash from Financing (Quarterly) | -6.538M |
| Free Cash Flow | 40.26M |
| Free Cash Flow Per Share (Quarterly) | 0.0091 |
| Free Cash Flow to Equity (Quarterly) | 9.555M |
| Free Cash Flow to Firm (Quarterly) | 5.541M |
| Free Cash Flow Yield | 15.22% |